PD-1 blockade enhances cytokine-induced killer cell-mediated cytotoxicity in B-cell non-Hodgkin lymphoma cell lines

The clinical utility of immune checkpoint inhibitors, such as programmed cell death protein 1 (PD-1) and programmed death-ligand 1 (PD-L1) inhibitors used alone or in combination with other therapies, is currently gaining attention. In this particular scenario, the inclusion of cytokine-induced kill...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yutao, Sharma, Amit, Bloemendal, Maurits W.J.R., Schmidt-Wolf, Roland, Kornek, Miroslaw, Schmidt-Wolf, Ingo G.H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8243082/
https://www.ncbi.nlm.nih.gov/pubmed/34257721
http://dx.doi.org/10.3892/ol.2021.12874

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8243082/
https://www.ncbi.nlm.nih.gov/pubmed/34257721
http://dx.doi.org/10.3892/ol.2021.12874

Ejemplares similares